In this study, we also demonstrated that RPS3 is released from tumor cells following treatment with an anti-cancer drug, and that this released RPS3 can affect the surrounding DCs expressing TLR4 in the tumor microenvironment. The gene discussed is RPS3; the disease is cancer.